mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.004 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.004 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |